Literature DB >> 16841624

Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year prospective study.

Claudi L H Bockting1, Philip Spinhoven, Maarten W J Koeter, Luuk F Wouters, Aart H Schene.   

Abstract

OBJECTIVE: Depression is a recurring disease. Identifying risk factors for recurrence is essential. The purpose of this study was to identify factors predictive of recurrence and to examine whether previous depressive episodes influence vulnerability for subsequent depression in a sample of remitted recurrently depressed patients.
METHOD: Recurrence was examined prospectively using the Structured Clinical Interview for DSM-IV Axis I Disorders in 172 euthymic patients with recurrent depression (DSM-IV) recruited from February 2000 through September 2000. Illness-related characteristics, coping, and stress (life events and daily hassles) were examined as predictors.
RESULTS: Risk factors for recurrence were a high number of previous episodes, more residual depressive symptomatology and psychopathology, and more daily hassles. Factors with both an increasing and decreasing pathogenic effect with increasing episode number were detected.
CONCLUSION: We found some support for dynamic vulnerability models that posit a change of vulnerability with consecutive episodes. Preventive interventions should be considered in patients with multiple recurrences, focusing on residual symptomatology and specific coping styles.

Entities:  

Mesh:

Year:  2006        PMID: 16841624

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  26 in total

1.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

2.  Bouncing back: remission from depression in a 12-year panel study of a representative Canadian community sample.

Authors:  Esme Fuller-Thomson; Marla Battiston; Tahany M Gadalla; Sarah Brennenstuhl
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-09       Impact factor: 4.328

3.  Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study.

Authors:  Carlos M Grilo; Robert L Stout; John C Markowitz; Charles A Sanislow; Emily B Ansell; Andrew E Skodol; Donna S Bender; Anthony Pinto; M Tracie Shea; Shirley Yen; John G Gunderson; Leslie C Morey; Christopher J Hopwood; Thomas H McGlashan
Journal:  J Clin Psychiatry       Date:  2010-06-15       Impact factor: 4.384

4.  Depressive symptom trajectories during and after adjuvant treatment for breast cancer.

Authors:  Kristine A Donovan; Brian D Gonzalez; Brent J Small; Michael A Andrykowski; Paul B Jacobsen
Journal:  Ann Behav Med       Date:  2014-06

5.  Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Todd W Dunn; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2007-06

6.  Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample.

Authors:  Andrew E Skodol; Carlos M Grilo; Katherine M Keyes; Timothy Geier; Bridget F Grant; Deborah S Hasin
Journal:  Am J Psychiatry       Date:  2011-01-18       Impact factor: 18.112

7.  Is liability to recurrent major depressive disorder present before first episode onset in adolescence or acquired after the initial episode?

Authors:  Jeremy W Pettit; Chelsey Hartley; Peter M Lewinsohn; John R Seeley; Daniel N Klein
Journal:  J Abnorm Psychol       Date:  2013-05

8.  Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.

Authors:  Cuneyt Tegin; Gulay Tegin; Rif S El-Mallakh
Journal:  Psychopharmacol Bull       Date:  2018-01-15

9.  Sex differences in clinical predictors of depression: a prospective study.

Authors:  Maria A Oquendo; Jason Turret; Michael F Grunebaum; Ainsley K Burke; Ernest Poh; Ellen Stevenson; J John Mann; Hanga Galfalvy
Journal:  J Affect Disord       Date:  2013-06-02       Impact factor: 4.839

10.  Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

Authors:  A A Nierenberg; M M Husain; M H Trivedi; M Fava; D Warden; S R Wisniewski; S Miyahara; A J Rush
Journal:  Psychol Med       Date:  2009-05-22       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.